Researchmoz added Most up-to-date research on "Allergic Rhinitis Drugs In Global Market Will Grow At A CAGR Of 0.95% For The Period From 2016 - 2020" to its huge collection of research reports.
Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative forms of treatment are also employed in certain cases.
Technavios analysts forecast the global allergic rhinitis market to grow at a CAGR of 0.95% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs market for the period 2016-2020. To calculate the market size, it considers revenue generated from the sales of prescription and off-label drugs used to treat allergic rhinitis.
The market is divided into the following segments based on geography:
Americas
APAC
Europe
Technavio's report, Global Allergic Rhinitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
GlaxoSmithKline
Meda Pharmaceuticals
Merck
Sanofi
UCB
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=565522
Other prominent vendors
Adamis Pharmaceuticals
Alcon
Alergo Pharma
ALK-Abell
Allergy Therapeutics
Almirall
Ampio
Anergis
Apotex
Ares Life Sciences
Array BioPharma
Aspen Pharmacare
Atopix Therapeutics
Barr Laboratories
Belcher Pharmaceuticals
Circassia Pharmaceuticals
Market driver
Increased prevalence of allergic rhinitis
For a full, detailed list, view our report
Market challenge
Patent expiries and competition from generic drugs
For a full, detailed list, view our report
Market trend
Increased R&D
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Browse More Details @ http://www.researchmoz.us/global-allergic-rhinitis-drugs-market-2016-2020-report.html
Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative forms of treatment are also employed in certain cases.
Technavios analysts forecast the global allergic rhinitis market to grow at a CAGR of 0.95% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs market for the period 2016-2020. To calculate the market size, it considers revenue generated from the sales of prescription and off-label drugs used to treat allergic rhinitis.
The market is divided into the following segments based on geography:
Americas
APAC
Europe
Technavio's report, Global Allergic Rhinitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
GlaxoSmithKline
Meda Pharmaceuticals
Merck
Sanofi
UCB
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=565522
Other prominent vendors
Adamis Pharmaceuticals
Alcon
Alergo Pharma
ALK-Abell
Allergy Therapeutics
Almirall
Ampio
Anergis
Apotex
Ares Life Sciences
Array BioPharma
Aspen Pharmacare
Atopix Therapeutics
Barr Laboratories
Belcher Pharmaceuticals
Circassia Pharmaceuticals
Market driver
Increased prevalence of allergic rhinitis
For a full, detailed list, view our report
Market challenge
Patent expiries and competition from generic drugs
For a full, detailed list, view our report
Market trend
Increased R&D
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Browse More Details @ http://www.researchmoz.us/global-allergic-rhinitis-drugs-market-2016-2020-report.html
